Product Information
BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0220 per EA under NDC 16729020001. Its NADAC has been published 490 times since Jan 4, 2017.
FDA first approved this application on Dec 30, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729020001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202557FDA Approved
12/30/2014
TE Code
AB
On Market Since
12/15/2016
Price Statistics
The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 490 times since Jan 4, 2017, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0220 per EA |
|---|---|
| All-time high | $0.0415 (Jan 11, 2017) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0224 |
| 52-week low | $0.0214 |
| Median price | $0.0285 |
| Average price | $0.0286 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 490 |
| Tracking since | Jan 4, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
+2.0%
1Y
-1.4%
3Y
-14.9%
5Y
-17.2%
All
-46.9%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0220 per EA (NDC 16729020001), effective May 20, 2026.
How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 46.9%. It has been tracked across 490 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?
Since Jan 4, 2017, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0415 (Jan 11, 2017), with a median of $0.0285 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 5 MG TABLET, is $0.0217 per EA — about 1% below BUSPIRONE HCL 5 MG TABLET.
Who manufactures BUSPIRONE HCL 5 MG TABLET?
BUSPIRONE HCL 5 MG TABLET (NDC 16729020001) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.